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Investigations into  the mechanism of recovery from lobar pneu- 
monia of recent years have brought forward an increasing amount of 
data to show that the principal evidence of acquired immunity con- 
sists in the development of humoral immune substances at or about 
the time of crisis.  Yet the majority of authors writing on this subject 
express considerable caution in drawing conclusions as to the causal 
relation between the immune bodies and the recovery process even 
though certain of these substances or reactions have been shown to be 
directly concerned in the destruction of pneumococci and protection of 
the body from invasion.  The reasons for this reservation of judgment 
are principally as follows:  First, the occurrence of immune substances 
in the serum has not been observed as a constant phenomenon in all 
cases recovering from  pneumonia;  second, the appearance of these 
immune bodies, while generally coinciding with the onset of recovery, 
may occur 1 or 2 days before crisis or in some cases not until after- 
wards;  third,  serum  immunity has  been  detected  infrequently in 
cases  terminating  fatally;  fourth,  while  the  promotion  of  phago- 
cytosis  and  intracellular destruction has  been  found  to  be  one  of 
the chief manifestations of acquired antipneumococcus serum action, 
the evidence for pneumococcidal power of the  blood at the  time of 
recovery is  not  generally considered as  convincing.  Furthermore, 
doubt has been cast on the importance of phagocytosis as a factor in 
the disposal of pneumococci in the body by the failure to demonstrate 
any degree of engulfment of these microorganisms by the cells of the 
lung exudate secured from patients  during the  period of recovery. 
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Finally, the fact that the introduction of large quantities of immune 
serum containing a high concentration of specific antibodies has been 
found by a  number of investigators to be ineffective in cases of pneu- 
monia after the 2nd or 3rd day of the disease, raises the question as to 
the ultimate r61e played by these serum substances. 
The above considerations have led certain workers to  seek other 
explanations for the sudden termination of infection in lobar pneu- 
monia.  Changes in the H  ion concentration of pneumonic exudate in 
relation to the acid death-point of pneumococci have been studied (1). 
Investigation of the mobilization of enzymes in the blood at the time of 
crisis  (2)  have also brought to light interesting facts but they do not 
afford a satisfactory interpretation of the recovery process. 
Our findings in a study of experimental pneumococcus infection in 
cats and rabbits  (3)  suggested that it would be profitable to  pursue 
further by the same methods the inquiry as to the relation of acquired 
humoral immunity to  the mechanism of recovery from lobar pneu- 
monia  in  man.  It  was  found  that  at  the  time  of  recovery from 
experimental disease there appeared constantly in the serum, immune 
properties  characterized  not  only  by  opsonic,  agglutinative,  and 
mouse-protective activity,  but  also  by  the  power to  promote  to  a 
marked degree the killing of virulent pneumococci in rabbit serum- 
leucocyte mixtures.  None of these changes occurred in animals with 
fatal infection.  The degree of pneumococcus-killing power potential 
in the recovered animal's blood made it appear that this action played 
an  important  part  in  the  disposal  of  pneumococci.  While  the 
development of humoral immune bodies was usually more marked and 
could be more closely related to the onset of recovery in the pneumo- 
coccus-resistant animal (the cat) than in the susceptible animal  (the 
rabbit), yet the latter showed the same type of serum immune change 
and hence it seemed probable that in the human, whose resistance lies 
somewhere between  that  of  these  two  animals,  a  similar  immune 
reaction occurs. 
Methods. 
The methods employed in  carrying  out  the pneumococcidal, opsonic, and 
agglutinative tests  have  been  described in  previous publications  (4-6).  The 
pneumococcidal-promoting  power of the serum was tested by adding it in progres- 
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TABLE  I. 
Determination  of Pne~mococcidal-Promoting Power of Serum during Course of Lobar 
Pneumonia, Pneumococcus Type H. 
Human serum dilution 0.1 ce.  +  normal rabbit serum 0.2 ce.  +  rabbit leuco- 
cyte suspension 0.1 co. +  pneumococcus suspension  0.1 ce. 
Serum sample in 
relation to lysis 
2 days before 
1 day before 
Day beginning 
Day completed 
3 days after 
12 days after 
Controls 
Amount of 
standard  Dilutions 
pneumo-  human 
COCcus  serunl 
suspension 
10  -e**  1-10 
"  1-20 
"  1-10 
"  1-20 
"  1-10 
"  1-20 
"  1-40 
"  1-80 
"  1-160 
"  1-40 
"  1-80 
"  1-160 
"  1-320 
"  1-640 
"  1-1280 
Growth as shown by color changes 
at hrs.* 
16 
++++ 
++++ 
++++ 
++++ 
0 
0 
++++ 
++++ 
++++ 
0 
0 
0 
0 
++++ 
++++ 
"  1-40  0 
"  1-80  0 
"  1-160  0 
"  1-320  0 
"  1-640  ++++ 
"  1-1280  ++++ 
"  1-20  0 
"  1~0  ++++ 
"  1-80  ++++ 
"  1-160  ++++ 
"  1~20  ++++ 
"  1-640  ++++ 
10  -7  0  ++++ 
"  0  ++++ 
0 
++++ 
48  72 
0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
Pneumococci 
in stained 
film at 72 
hrs, 
+ 
+ 
+ 
+ 
0 
+ 
+ 
+ 
+ 
0 
0 
0 
0 
+ 
+ 
0 
0 
0 
0 
+ 
+ 
0 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
* Degrees of methemoglobin  formation. 
** This amount represents 500 to 1000 pairs of pneumococci. 516  MECHANISM  OF  RECOVERY FROM LOBAR PNEUMONIA 
highly virulent pneumococci.  Since these  mixtures  have no growth-inhibitory 
action  on  such  organisms,  any pneumococcidal  effect  which  occurs  may be 
attributed directly to the added test serum.  The amounts of the various  constit- 
uents used in the reaction are given in Table I.  Opsonic and agglutinative tests 
were performed by mixing pneumococci which had completed their active growth 
phase 1 with serum, in a ratio of 1 part of pneumococcus suspension  to 20 parts of 
serum.  After sensitization  for 1 hour the pneumococci were then separated from 
the serum  by centrifugation,  the sedimented  mass  broken up with  a  capillary 
pipette, macroscopic agglutination  noted,  and phagocytic tests performed  in the 
usual  way with especially  prepared rabbit leucocytes.  The degrees of opsonic 
action and agglutination were noted in terms of plus signs ranging from +  slight 
but definite,  to  + + + +  which was very marked.  Since  all  the specimens  of 
serum from one patient, inactivated after separation and kept on ice, were tested at 
one time it was possible to make comparative readings  on them.  The different 
tests, pneumococcidal, opsonic, agglutination,  and mouse protection, were usually 
made on the same day.  Occasionally this was not possible. 
The pneumococci used in the tests with Type I sera were highly virulent strains. 
The homologous organisms isolated from both blood and sputum as well as a stock 
culture were used.  In the testswith serum from pneumonia Type II and Group 
IV it was necessary to use the serum and leucocytes of young rabbits as none of the 
strains from these patients were virulent,  nor could they be made virulent for full 
grown rabbits (7).  Controls with young rabbit serum and leucocytes showed no 
opsonic or agglutinative  action for these Type II and Group IV strains of pneumo- 
cocci which were highly virulent for the young animal. 
Clinical Cases. 
The  following  study  represents  observations  made  on  seventeen 
cases of lobar pneumonia comprising five cases of Pneumococcus Type 
I, six of Type II, two of Type II atypical, and four Group IV.  Sixteen 
of the patients recovered.  One died. 
It may be stated briefly at the outset that the results of the study 
in human cases were essentially the same as those obtained in cats with 
experimental  pneumococcus  infection.  Furthermore  no  constant 
differences  in  reaction  were  observed  between  the  three  types  of 
pneumonia  studied.  The  blood  serum  in  the  early  stages  of  the 
disease  was  found  to  be  without  pneumococcus immune  principles. 
Then,  about  the  time  of  crisis,  the  serum  acquired  demonstrable 
1 Type II pneumococci, however, were used in the active growth phase.  The 
significance of the growth phase  in relation  to opsonic and agglutination tests is 
discussed in an earlier publication  (J. Exp. Med., 1927, xlvi, 239). R.  ]~. P.  SIA~  O.  l:I.  ROB~ERTSON~  AND  S.  T.  WOO  ,517 
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pneumococcidal-promoting  power  as  well  as  opsonic,  agglutinative, 
and  mouse-protective  properties.  Text-fig.  1  illustrates  well  the 
sequence of changes  found to occur in  cases where the observations 
were begun early in the disease course.  Tests on the blood specimens 
taken from this patient on the 4th and 5th days of disease were nega- 
tive (Table I).  On the 6th  day, which marked the  beginning of the 
fall in  temperature,  the  serum  showed the  titer  of pneumococcidal- 
promoting  substances  of  1:10.  Opsonins  and  agglutinins  were  not 
demonstrable at this time.  On the 8th day when the temperature had 
reached  normal  the  titer  of  pneumococcidal-promoting  substances 
had  risen  to  1:320  and  opsonins,  agglutinins,  and  mouse-protective 
bodies were evident. 
The occurrence of demonstrable immune substances in the blood as 
shown especially by the pneumococcidal-promoting  power,  appeared 
to coincide generally with the beginning of defervescence.  In only one 
instance (Text-fig. 4) were immune properties found in the serum more 
than  a  very short time  (hours)  before the temperature began to fall. 
In  one  other  case  pneumococcidal-promoting  substances  failed  to 
appear until  after the temperature  had reached normal.  It is  quite 
possible that a more complete series of observations made immediately 
preceding the initiation  of recovery might  show a  constantly  earlier 
appearance of serum immune properties, although the results of tests 
such  as  are  exhibited  in  Text-figs.  1  and  3,  in  which  the  immune 
reactions were  found to  be present  initially  to only a  slight  degree, 
suggest that they had not been detectable much earlier.  In support 
of this supposition is the fact that once this immune property appeared 
in the blood it showed in most instances a rapid quantitative increase3 
The titer of pneumococcidal-promoting substances usually reached 
its height within 48 to 72 hours.  Then after some days at this high 
level it began  to  fall.  Just how long  the  serum  continued  to  show 
immune  properties  was  not  determined  but that  the  persistence of 
passive immunity varies greatly from patient to patient was shown by 
the  finding  in  some cases that  all  traces  of humoral  immunity  had 
Our observations in experimental animals (3) in which a rapidly diminishing 
blood invasion occurred 24 to 48 hours before the termination of the disease make 
it seem highly probable that immune bodies are elaborated and perhaps present  in 
low concentration for some time before crisis. R.  ]~.  P.  SIA~  O.  IT.  ROBERTSON~  AND  S.  T.  WOO  519 
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disappeared within 10 days after crisis (Case 12827, Text-fig. 3), while 
in others, and these constituted the majority, at the end of weeks or 
months  serum  immune properties  were  still  evident  though  much 
diminished.  Note Case 4960,  Text-fig. 7, tested after 74 days.  The 
persistence of immune substances in  the serum seemed to be associ- 
ated to a  certain degree with the initial intensity of  immune body 
production.  Thus,  those  patients  in  whom  serum immunity  was 
demonstrable for the longest periods showed a relatively high pneu- 
mococcidal-promoting serum titer at outset, and those in whom the 
serum immunity disappeared earlier showed an initial low or at most 
moderately elevated titer.  However, these observations are too few 
to permit any conclusions concerning this point. 
Only one patient of the sixteen recovering showed a positive blood 
culture.  This was taken on the day before the appearance of serum 
immune substances which occurred at the time of crisis, hence it was 
not possible in this series of cases to determine whether the occurrence 
of  detectable  pneumococcidal-promoting  substances  in  the  blood 
marked the termination of blood invasion as was always found to be 
the case in cats recovering from experimental pneumococcus infection. 
In the majority of the cases all the different manifestations of serum 
immunity became demonstrable at the same time as in  Cases  12656 
and 3193,  Text-figs. 2 and 4.  In others,  the appearance of pneumo- 
coccidal-promoting power in  the  serum seemed to  precede or occa- 
sionally  lag  behind  the  occurrence  of  opsonic,  agglutinative,  and 
mouse-protective action  (Text-figs.  1,  3,  and  6).  These  variations 
may, however, be more apparent than real since the different means 
employed to bring out the several reactions may not be strictly com- 
parable  in  their power to  detect minute  traces of the immune sub- 
stance or substances.  Furthermore, a  comparison of the  changing 
intensity  of  the  four  reactions  through  the  period  of  observation 
revealed a general parallelism.  This was closest between the pneumo- 
coccidal-promoting power and the mouse-protective action which are 
more  susceptible  to  accurate  quantitative  estimation  than  are  the 
opsonic and agglutinative reactions as carried out in  this work.  It 
was  found frequently, especially at  the beginning of recovery, that 
equal parts of serum and pneumococcus suspension failed to bring out 
opsonic activity while employing 20 parts of serum to 1 of suspension 
produced a well defined reaction. 524  MECHANISM  OF RECOV]~R¥ I?ROM LOBAR  PNEUMONIA 
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In striking contrast to the findings  in  patients recovering, are those 
made  on  the  case progressing  to  a  fatal  termination  (Text-fig.  8). 
Repeated  tests  of the  blood  serum made  during  the  course of  the 
disease in this patient failed to reveal any evidence of the development 
of immune properties.  Tests for opsonic, agglutinative, and mouse- 
protective action were not made in  this  case but  judging from the 
findings in experimental pneumococcus infection (3), it is probable that 
these reactions were also lacking here.  There was a persistent slight 
blood invasion but it did not increase during the course of the disease. 
Specificity  of Immune Substances. 
The pneumococcidal-promofing substances occurring in the serum 
at recovery were found to be strictly type-specific.  Pneumococcidal 
tests in which one serum was used with several types of pneumococci 
and also  several  types  of  serum with one type  of  pneumococcus, 
showed killing of the pneumococci only in those tubes containing the 
homologous  serum  and  organisms.  The  opsonic  and  agglutinative 
reactions were also found to be specific to type. 
White  Blood  Cells. 
The observations on the leucocytic response in this series of pneu- 
monia patients are much less complete than those made in the experi- 
mental infected animals  described in  the preceding  paper  to  which 
reference has been made (3).  However, certain points  are apparent 
and  these  are  in  general similar to  the findings in  the experimental 
disease.  In the majority of the human cases there was a moderately 
increased or high white count  just  before the  onset  of recovery.  In 
others, however, the number of leucocytes remained about normal and 
in one instance slightly below normal during the critical period (see 
Text-figs. 1 and 2).  The fatal case showed an increasing white count 
towards the end of the disease reaching 35,000 the day before death? 
These findings are in agreement with the inferences drawn from  the 
animal studies, namely, that the leucocytes probably  play  a secondary 
rSle in the mechanism of recovery from pneumococcus infection, but 
a  There was no  evidence  of  complications  in this  patient although  this  could  not 
be  definitely  determined  since  an autopsy was not obtained. 526  MECHANISM  OF  RECOVERY  I~'P.OM  LOBAR  PNEUMONIA 
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the well substantiated clinical observation that a  low white count is 
generally to be considered as of unfavorable prognostic import, indi- 
cates that a certain minimum number of white blood cells are neces- 
sary to provide suitable conditions for recovery. 
Complications and the Presence of Immune Substances. 
Two of the patients in this series, a Group IV and a Type II pneumo- 
coccus pneumonia, developed empyema at  a  time when there were 
demonstrable pneumococcidal-promoting properties in the serum.  In 
one instance the titer was low,  1:40, in the other it was 1: 640.  Both 
patients recovered. 
DISCUSSION. 
While the above  findings do not warrant the conclusion that  the 
development of specific antipneumococcus properties occurs constantly 
in the serum of all patients recovering from lobar pneumonia, they do 
indicate that these serum changes are of very common occurrence and 
perhaps are present to varying degrees in every case.  The fact that 
certain workers, Chickering (8), Clough (9), Lister  (10),  and others, 
have failed to demonstrate the presence of opsonins and agglufinins in 
a small per cent of pneumonia cases at the time of crisis may simply 
indicate the occurrence  of considerable variation in the degree of anti- 
body response.  We have shown that the use of equal parts of serum 
and pneumococcus suspension employed in the earlier studies may fail 
to bring out a low concentration of opsonins and agglutinins.  Chicker- 
ing mentions that  in some of his  cases agglutinins were detected on 
1  day  only.  However,  the  absence  of  mouse-protective action in 
the critical and postcrifical serum observed by certain investigators in 
occasional cases recovering from lobar pneumonia is of greater signifi- 
cance on account of the marked sensitiveness of this test.  4  Dochez 
(11)  found in a  series of ten recovering cases that the serum of one 
failed to  show protective  power  against  the  homologous organism. 
Clough  (12)  studying  twelve  cases  found  protective  action  in  the 
serum of only nine.  In the three patients in whom the serum showed 
no protection, only one serum specimen was obtained in each case and 
this, 1 to 3 days following recovery.  Other authors, and most recently 
* Mouse protection seems to be fully as delicate an indication of the presence of 
antipneumococcus immune substances  as  is  the  test for  pneumococcidal  action. It.  It.  P.  SIA,  O.  It.  ROBERTSON,  AND  S.  T.  WOO  529 
Baldwin and Rhoades  (13),  have found protective substances con- 
stantly in the serum of recovering patients. 
Previous  studies  by other investigators have  shown  that  in  the 
majority  of  cases  the  appearance  of  circulating  immune  bodies 
coincides  closely with  the  time of  crisis  or  lysis.  But  in  a  small 
percentage  of  pneumonia  patients  immune  substances  have  been 
detected 1 to 2  days beforehand.  Baldwin and Rhoades (13) found 
protective bodies in twelve out of twenty cases at least 2 days prior to 
the day of crisis.  However, a  number of their  reported  cases  had 
received specific therapy of one kind or another so that it is not clear 
how many of them developed the passive immune properties spon- 
taneously.  Does this occasional finding of immune properties in the 
serum sometime before crisis  constitute a  serious objection  to the 
assumption that immune body development is related intimately to 
the mechanism of recovery?  While the relationship between demon- 
strable humoral immunity  and recovery  would be much clearer  if serum 
immune substances always appeared at or immediately before crisis, 
the fact that they may be present in the blood a day or two before the 
apparent beginning termination of the disease process does not seem to 
provide a sufficient reason for denying them an important r61e in the 
recovery mechanism.  We know relatively little about conditions in 
the  body  which  influence  the  functioning of  opsonins,  protective 
bodies,  etc.  Furthermore, structural peculiarities in the local lesion 
may well produce variation in  the rate at which the immune sub- 
stances penetrate or there may be other factors of a  more general 
nature upon  which the  effective action of these antipneumococcus 
bodies  largely depends.  May not the early appearance of acquired 
immune bodies in a given case of lobar pneumonia represent a condi- 
tion somewhat analogous to that which is frequently observed after 
the  introduction  of  anfipneumococcus serum  Type  I?  Following 
the injection of  an  adequate  amount of  immune serum the blood 
acquires immune properties but the crisis may not occur for several 
days.  However, the blood invasion ceases and the pneumonic process 
stops spreading.  It has been shown by Baldwin and Cecil (14) that 
the appearance of protective bodies in  the  blood of spontaneously 
recovering cases marks the termination of blood invasion, a  finding 
with which our observations in experimental pneumococcus infection 
agree.  It is not possible  that the spread of the pneumonic process 530  MECHANISM  OF  RECOVERY  FROM  LOBAR  PNEUMONIA 
also ceases at this time?  Our one patient in whom humoral immunity 
was detected 12 to 18 hours before crisis (Text-fig. 4) did show physical 
signs of beginning resolution 24 hours before the critical fall in tem- 
perature.  We have found no observations on this point in the litera- 
ture. 
There exists also the possibility that the termination  of the disease 
depends  on  the  development  of  antitoxic  as  well  as  antibacterial 
immunity, as was suggested years ago by Cole (15), Wadsworth (16), 
and others. 
Failure  to detect immune  substances until 24 hours or more  after 
crisis  has  been  reported  less  frequently  than  their  early  appear- 
ance.  This  condition  might  be  due  to  an  unusually  marked  neu- 
tralization  of perhaps  a  rather low concentration  of these bodies at 
the time of recovery. 
The finding of antipneurnococcus immune properties in the serum of 
patients going on to a fatal termination has been confined as far as we 
can  determine  to  cases developing  complications.  In  Baldwin  and 
Cecil's  (14)  three  fatal  cases  showing  circulating  humoral  immune 
substances there was a  complicating empyema.  In Clough's  (9)  one 
reported  case,  an  active  endocarditis  was  probably  present.  The 
development of such secondary foci of infection in patients in whom 
the pneumonic process has been checked and who show evidence of 
considerable serum immunity is a further indication of the complexity 
of the recovery mechanism. 
Of  even  more  importance  than  the  finding  of antipneumococcus 
substances in the serum during recovery is information as to their mode 
of action.  The  demonstration  in  this  study  that  a  serum  showing 
such  properties  possesses the  power  to  promote  the  destruction  of 
highly  virulent  pneumococci  provides  more  direct  evidence  of  the 
function of these immune bodies than  has heretofore been obtained. 
That immune serum promotes phagocytosis  and  intraceUular  diges- 
tion  in  the  body as  it  does in  the  test-tube  seems highly  probable 
although it should be pointed out that we have made no determina- 
tions of the activity of  the pneumonic leucocytes.  Investigations in 
this  field by other  workers  (17-19)  have  shown  that  the  leucocytes 
apparently function actively during the height of the disease.  5 
5 A discussion of this  phase of the  subject  is taken  up in  an earlier publica- 
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The fact that the above findings in human cases of lobar pneumonia 
are in practically entire accord with the observations made in cats 
undergoing experimental pneumococcus infection enhances consider- 
ably the significance of the development of serum immune bodies at the 
time of crisis.  In the cat it was possible to show that the acquisition 
of humoral immunity was associated with greatly increased antipneu- 
mococcus  resistance.  Furthermore  variations  in  the  degree  of 
acquired immunity were found to be associated in a general way with 
the  corresponding  fluctuations  in  concentration  of  demonstrable 
serum immune bodies.  But while these observations suggest that the 
reaction of the body to pneumococcus invasion is the same in animals 
and  in  man  despite  the  great  dissimilarity in  the  character of the 
lesions produced, they do not indicate certainly that the mechanism of 
recovery is identical in both instances.  The peculiar character of the 
local  lesion  in  lobar  pneumonia  would  seem  to  introduce  certain 
special conditions to be reckoned with in the human body's defense 
against this organism and which may involve the operation of processes 
other  than  those  essential  for  recovery  in  less  intensely  localized 
pneumococcus  infection.  In  a  discussion  of  this  question,  Cole 
(20)  suggests that the destruction of pneumococci in the lung lesion 
may depend on local factors quite different from those responsible for 
the destruction of the bacteria in the circulating blood.  He mentions 
the marked changes which occur in  the resolving lung exudate, the 
solution of fibrin acting as a possible relief from tension and affording 
an outlet for the exudate and the production of chemical compounds, 
soaps, fatty acids, etc., shown to have a destructive action on pneumo- 
cocci.  However,  he  points  out  the  difficulty in  inferring  that  the 
crisis depends mainly on the resolution of the exudate, in that these 
two  processes do  not necessarily occur synchronously.  Cole's  con- 
clusion (21)  that recovery depends largely on an adequate concentra- 
tion of immune bodies in the blood is supported by the observations 
presented in this paper. 
SIJM~AR¥. 
Employing  a  method  devised  for  the  investigation  of  natural 
immunity and experimental pneumococcus infection, a study has been 
made of the serum immune changes occurring during the course of 532  MECHANISM  OF RECOVERY  FROM  LOBAR  PNEUMONIA 
lobar pneumonia due to Pneumococcus Types I  and II and Group IV, 
in  man.  It  was  found  that  at  the  time  of crisis  or lysis the  blood 
serum acquired constantly the property of promoting pneumococcus 
killing to a relatively marked degree.  Other evidences of antipneumo- 
coccus reaction--mouse  protection,  opsonins,  and  agglutinins--were 
also demonstrable in the blood at this time.  These immune changes 
appeared  in  the majority of cases at  the  beginning  of recovery and 
failed  to  occur when the  disease  terminated  fatally.  The  fact that 
these  observations  in  human  cases  are  practically  identical  with 
previous findings  in  the  experimental  disease in  cats,  enhances  con- 
siderably  the  significance  of  the  development  of  serum  immune 
bodies at  the  time of crisis since in  the  experimental  animal  it was 
possible to show that  the acquisition of passive immunity  was asso- 
ciated with greatly increased antipneumococcus resistance. 
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